Results 91 to 100 of about 46,680 (279)

Recent Advances in Nanomedicine‐Mediated Abdominal Aortic Aneurysm Treatment

open access: yesSmall Methods, EarlyView.
Bridge the gap. Emerging strategies such as nanoparticle platforms and cell therapies may help advance the medication management of abdominal aortic aneurysm from laboratory to clinical application. By enhancing the precision, efficacy, ad comprehensiveness of drug delivery, a wide range of studies have obtained positive outcomes and are summarized in ...
Xinchen Lu, Quanyin Hu
wiley   +1 more source

Rhabdomyolysis due to Lamivudine administration in acute viral hepatitis B infection: a case report from Malaysia

open access: yesElectronic Physician, 2014
Rhabdomyolysis is a serious but rare side effect of Lamivudine treatment. Therefore, appropriate biochemical monitoring should be undertaken when it is used in the treatment of hepatitis B.
Janudin Baharin   +2 more
doaj   +1 more source

Embedding Pharmacogenetics Into Clinical Practice to Improve Patient Outcomes

open access: yesAnnals of Human Genetics, EarlyView.
ABSTRACT Pharmacogenomics, the use of germline genomic data to guide prescription to improve effective and safer medication, holds promise as a clinical intervention. To date in most health systems, there has been limited uptake of pharmacogenomic testing confined to a few single drug–gene associations.
John Henry McDermott   +3 more
wiley   +1 more source

Localized Rhabdomyolysis Associated With Testosterone Enanthate for Gender-Affirming Hormonal Therapy

open access: yesAACE Clinical Case Reports, 2022
Background/Objective: Rhabdomyolysis is a condition characterized by the destruction of skeletal muscle tissue that leads to systemic complications. We present a case of gender-affirming intramuscular (IM) testosterone therapy precipitating localized ...
Rashmi Reddy, MD   +2 more
doaj  

Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate‐to‐Severe Atopic Dermatitis

open access: yesAllergy, EarlyView.
Data were included from adolescents with moderate‐to‐severe AD treated with the JAK1 inhibitor abrocitinib (200 mg/100 mg) across JADE clinical trials. Improvements in skin clearance (per EASI‐75) and itch (per PP‐NRS4) were maintained for up to 112 weeks with both abrocitinib doses.
Amy S. Paller   +13 more
wiley   +1 more source

dsDNA-induced AIM2 pyroptosis halts aberrant inflammation during rhabdomyolysis-induced acute kidney injury.

open access: yesCell Death and Differentiation, 2022
C. Baatarjav   +6 more
semanticscholar   +1 more source

Pantethine therapy dramatically rescues end‐stage failing heart in a patient with deficiency of coenzyme A biosynthesis

open access: yes
ESC Heart Failure, EarlyView.
Violette Goetz   +9 more
wiley   +1 more source

Suspected marsh mallow (Malva parviflora) toxicosis in ponies—Case cluster including an asymptomatic survivor

open access: yesAustralian Veterinary Journal, EarlyView.
There is limited published information on Malva parviflora toxicosis in horses. Four previously reported cases all resulted in death or euthanasia. The aim of this cluster investigation was to describe historical, clinical and clinicopathological findings of four ponies with suspected M.
J Bauquier   +3 more
wiley   +1 more source

Rhabdomyolysis Associated with Parainfluenza Virus

open access: yesCase Reports in Infectious Diseases, 2013
Influenza virus is the most frequently reported viral cause of rhabdomyolysis. A 7-year-old child is presented with rhabdomyolysis associated with parainfluenza type 2 virus.
Miltiadis Douvoyiannis   +4 more
doaj   +1 more source

Global Perspectives on Kava: A Narrative Systematic Review of the Health Effects, Economic and Social Impacts and Policy Considerations

open access: yesDrug and Alcohol Review, EarlyView.
ABSTRACT Introduction Kava is a plant‐based drug central to many Pacific Island cultures, yet its physiological and psychological effects remain contested and poorly understood. Additionally, the broader social, economic, and policy consequences of kava trade and consumption are unclear.
George Economidis   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy